Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of DWJ1506 and DWJ1507 in Dyslipidemia
NCT04772443Phase 3Unknown
- Sponsor
- Daewoong Pharmaceutical
- Start
- Feb 2021
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of rosuvastatin, ezetimibe in dyslipidemia, sponsored by Daewoong Pharmaceutical. Status: unknown.
02
Drugs
rosuvastatinezetimibe
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT04772443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04772443.